Quantbot Technologies LP Puma Biotechnology, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.21 - $4.82 $7,956 - $17,352	3,600 New	3,600 $11,000
Q3 2022 Nov 07, 2022	BUY	$2.27 - $3.84 $4,131 - $6,988	1,820 Added 68.19%	4,489 $10,000
Q2 2022 Aug 09, 2022	SELL	$1.64 - $3.3 $5,904 - $11,880	-3,600 Reduced 57.43%	2,669 $7,000
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $17,466 - $26,568	-8,200 Reduced 56.67%	6,269 $18,000
Q4 2021 Feb 11, 2022	BUY	$2.85 - $6.58 $41,236 - $95,206	14,469 New	14,469 $43,000
Q4 2020 Feb 12, 2021	SELL	$7.78 - $12.13 $20,772 - $32,387	-2,670 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $24,225 - $28,407	2,550 Added 2125.0%	2,670 $26,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $841 - $1,588	120 New	120 $1,000
Q3 2019 Nov 12, 2019	SELL	$8.75 - $12.85 $49,000 - $71,960	-5,600 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.3 - $35.76 $68,880 - $200,256	5,600 New	5,600 $71,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.